New Heart Health Study Halted

Trials of a potential blockbuster cholesterol drug were halted after a safety board found the drug actually increased cardiovascular deaths.

The drug, made by Pfizer, was designed to increase levels of good cholesterol, which might lower the amount of plaque in heart arteries.

15,000 volunteers participated in the international study.

Half took the drug in combination with Lipitor, a drug that lowers bad cholesterol levels.

The other half took Lipitor alone.

An independent review board counted 82 deaths in the new drug group, compared to 51 deaths in the other group.

This drug was anticipated to be a new way to battle heart disease.

WNDU - Channel 16 54516 State Road 933 South Bend, IN 46637 Front Desk: 574-284-3000 Newsroom: 574-284-3016 Email:
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 4821816 -
Gray Television, Inc.